Cramer, citing sources, says the Bezos-Buffett-Dimon venture looks to cut out drug distributors
February 13, 2018 at 10:33 AM EST
A deal between Walgreens and AmerisourceBergen may not be the best move, CNBC's Jim Cramer says.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|